Search details
1.
A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis Clinical Trials.
Am J Respir Crit Care Med
; 207(10): 1376-1382, 2023 05 15.
Article
in English
| MEDLINE | ID: mdl-36790881
2.
Bacterial Factors That Predict Relapse after Tuberculosis Therapy.
N Engl J Med
; 379(9): 823-833, 2018 Aug 30.
Article
in English
| MEDLINE | ID: mdl-30157391
3.
Elevated Plasma Moxifloxacin Concentrations and SLCO1B1 g.-11187G>A Polymorphism in Adults with Pulmonary Tuberculosis.
Antimicrob Agents Chemother
; 62(5)2018 05.
Article
in English
| MEDLINE | ID: mdl-29463526
4.
Central monitoring in a randomized, open-label, controlled phase 3 clinical trial for a treatment-shortening regimen for pulmonary tuberculosis.
Contemp Clin Trials
; 104: 106355, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33713841
5.
Innovative Approaches to COVID-19 Case Investigation and Contact Tracing.
Public Health Rep
; 137(2_suppl): 5S-10S, 2022.
Article
in English
| MEDLINE | ID: mdl-36113066
Results
1 -
5
de 5
1
Next >
>>